...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: C'mon Pfizer do something

https://endpts.com/adding-billions-in-value-eli-lilly-succeeds-where-pfizer-failed-halting-breast-cancer-recurrence/

Ibrance (Palbociclib) is getting outclassed. Maybe time to add a synergistic BETi to it?

 

Share
New Message
Please login to post a reply